Panera lost diners by cutting portions and staff. It's reversing course to win them back
Panera Bread has unveiled a turnaround strategy to reverse years of traffic declines.
‘He lived alone in Section 8 housing’: My late uncle’s landlord disposed of his art collection. What can we do?
“The management company said they would store his belongings.”
Once you reach this magic number in emergency savings, ‘you no longer have to give up hope’ financially
While having $2,000 saved is still well below the amount financial planners recommend for a full emergency fund, surveys show that it is a critical threshold for people’s financial well-being. Here’s why.
Ford partners with Amazon for dealers to sell used vehicles online
Ford is partnering with Amazon for the automaker’s franchised dealers to be able to sell certified pre-owned vehicles through the online retail giant.
Jeep eyes U.S. comeback following yearslong sales troubles
Jeep has been in a rut. It has experienced six consecutive years of U.S. sales declines amid a leadership carousel, dearth of new products and push into luxury.
This stock trader was called a ‘market wizard’ — she’s now revealing how she performs her magic
Linda Raschke shares the secret to her successful trading career and how to play to win.
Mark Wahlberg's new $37 million mansion skyrocketed in value. Here's what fueled the megahome's extraordinary rise
The megahome’s price more than doubled since 2020, outpacing other luxury real estate markets.
The S&P 500’s next addition could be this red-hot tech stock
One analyst notes that Sandisk’s rapid growth this year has made it an “elephant” in the S&P’s small-cap index. That could drive its promotion to the big leagues.
E.W. Scripps stock surges 40% after Sinclair takes stake, pushes for a merger
Sinclair recently launched a strategic review that could result in a merger.
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month
The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.
